ÂÜÀòÂÒÂ×

Taro Fujimori is a seasoned professional in global regulatory science and CMC (Chemistry, Manufacturing, and Controls) with an extensive career spanning multiple companies in the biopharmaceutical industry. Currently serving as Senior Director at Moderna since May 2024, Taro previously held the role of Director at Ultragenyx Pharmaceutical Inc. and spent nearly a decade at AbbVie, where various leadership positions focused on managing regulatory submissions and overseeing CMC aspects of drug development. Taro's experience includes directing large teams, coordinating biologics development programs from preclinical stages to post-approval changes, and successfully preparing regulatory filings. Academic credentials include a Ph.D. in Biophysics from Brandeis University, an MBA from Columbia Business School and London Business School, and a Bachelor's degree in Biophysics from the University of Pennsylvania.